Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Child and Adolescent Psychopharmacology
|
November 6, 2007
Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo
Sitra Tauscher-Wisniewski, Mary Nilsson, Cathy Caldwell, et al.
British Journal of Pharmacology
|
November 18, 2009
Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling
Fui Goon Goh, Pei Yuen Ng, Mary Nilsson, et al.
Current Medical Research and Opinion
|
September 30, 2010
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis
Antonio Crucitti, Qi Zhang, Mary Nilsson, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19
Mary Nilsson, Brenda Crowe, Greg Anglin, et al.
Journal of Child and Adolescent Psychopharmacology
|
January 15, 2005
Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents
Mary Nilsson, Melissa J Joliat, Cherri M Miner, et al.
Cellular Signalling
|
April 22, 2008
G-protein-dependent and -independent pathways regulate proteinase-activated receptor-2 mediated p65 NFkappaB serine 536 phosphorylation in human keratinocytes
Fui Goon Goh, Callum M Sloss, Margaret R Cunningham, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Reference Limits for Outlier Analyses in Randomized Clinical Trials
Charles M Beasley, Brenda Crowe, Mary Nilsson, et al.
Journal of Biopharmaceutical Statistics
|
February 14, 2019
Adaptation of the robust method to large distributions of reference values: program modifications and comparison of alternative computational methods
Charles M Beasley, Brenda Crowe, Mary Nilsson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 5, 2002
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial
Graham J Emslie, John H Heiligenstein, Karen Dineen Wagner, et al.
The Journal of Biological Chemistry
|
March 14, 2012
Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4)
Margaret R Cunningham, Kathryn A McIntosh, John D Pediani, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Child and Adolescent Psychopharmacology
|
November 6, 2007
Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo
Sitra Tauscher-Wisniewski, Mary Nilsson, Cathy Caldwell, et al.
British Journal of Pharmacology
|
November 18, 2009
Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling
Fui Goon Goh, Pei Yuen Ng, Mary Nilsson, et al.
Current Medical Research and Opinion
|
September 30, 2010
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis
Antonio Crucitti, Qi Zhang, Mary Nilsson, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19
Mary Nilsson, Brenda Crowe, Greg Anglin, et al.
Journal of Child and Adolescent Psychopharmacology
|
January 15, 2005
Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents
Mary Nilsson, Melissa J Joliat, Cherri M Miner, et al.
Cellular Signalling
|
April 22, 2008
G-protein-dependent and -independent pathways regulate proteinase-activated receptor-2 mediated p65 NFkappaB serine 536 phosphorylation in human keratinocytes
Fui Goon Goh, Callum M Sloss, Margaret R Cunningham, et al.
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Reference Limits for Outlier Analyses in Randomized Clinical Trials
Charles M Beasley, Brenda Crowe, Mary Nilsson, et al.
Journal of Biopharmaceutical Statistics
|
February 14, 2019
Adaptation of the robust method to large distributions of reference values: program modifications and comparison of alternative computational methods
Charles M Beasley, Brenda Crowe, Mary Nilsson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 5, 2002
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial
Graham J Emslie, John H Heiligenstein, Karen Dineen Wagner, et al.
The Journal of Biological Chemistry
|
March 14, 2012
Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4)
Margaret R Cunningham, Kathryn A McIntosh, John D Pediani, et al.
Page
of 1